Y-Clone Medical Sciences Inc. was founded in Suzhou in 2013. The company’s proprietary technology is capable of inducing difficult antibodies such as broadly neutralizing antibodies against HIV using a designed V3 region as an antigen. The company focuses on developing diagnostically and therapeutically effective antibodies and designed vaccines against infectious diseases. We have successfully developed a broadly neutralizing antibody against HIV and specific antibodies against HPV 16 and 18. This platform technology can be applied to many areas.